The role of the T cell in autoimmune inflammation

T cells, in particular CD4+ T cells, have been implicated in mediating many aspects of autoimmune inflammation. However, current evidence suggests that the role played by CD4+ T cells in the development of rheumatoid inflammation exceeds that of activated proinflammatory T-helper (Th)1 effector cells that drive the chronic autoimmune response. Subsets of CD4+ T cells with regulatory capacity, such as CD25+ regulatory T (Treg) cells and Th2 cells, have been identified, and recent observations suggest that in rheumatoid arthritis the function of these regulatory T cells is severely impaired. Thus, in rheumatoid arthritis, defective regulatory mechanisms might allow the breakdown of peripheral tolerance, after which the detrimental Th1-driven immune response evolves and proceeds to chronic inflammation. Here, we review the functional abnormalities and the contribution of different T cell subsets to rheumatoid inflammation.

[1]  M. Tykocinski,et al.  Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 141 , 2004, The Journal of Immunology.

[2]  U. Wagner,et al.  CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis , 2002, The Journal of experimental medicine.

[3]  M. Waldor,et al.  Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. , 1985, Science.

[4]  M. Dougados,et al.  Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA 4 Ig , 2003 .

[5]  F. Powrie,et al.  Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[6]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[7]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[8]  Ehrenstein,et al.  Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .

[9]  M. Feldmann,et al.  Suppression of collagen-induced arthritis by continuous administration of IL-4. , 1997, Journal of immunology.

[10]  F. Breedveld,et al.  Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. , 1989, Cellular immunology.

[11]  B. Haynes,et al.  Increase in TCR gamma delta T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis. , 1992, Journal of Clinical Immunology.

[12]  P. Gregersen,et al.  Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. , 1996, Journal of immunology.

[13]  P. Lipsky,et al.  Altered memory T cell differentiation in patients with early rheumatoid arthritis. , 1999, Journal of immunology.

[14]  G. Crabtree,et al.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.

[15]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[16]  P. Tugwell,et al.  The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review. , 1994, British journal of rheumatology.

[17]  B. Haynes,et al.  Increase in TCRγδ T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis , 1992, Journal of Clinical Immunology.

[18]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[19]  Arthur Weiss,et al.  ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.

[20]  J. Farrés,et al.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies , 2000, Annals of the rheumatic diseases.

[21]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[22]  M. Herrmann,et al.  Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation1 , 2002, The Journal of Immunology.

[23]  V. Taneja,et al.  CD4 and CD8 T Cells in Susceptibility/Protection to Collagen-Induced Arthritis in HLA-DQ8-Transgenic Mice: Implications for Rheumatoid Arthritis1 , 2002, The Journal of Immunology.

[24]  N. Macdonald,et al.  Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. , 1977, Arthritis and rheumatism.

[25]  L. Davis,et al.  Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells , 2000, Arthritis research.

[26]  G. Panayi Targeting of cells involved in the pathogenesis of rheumatoid arthritis. , 1999, Rheumatology.

[27]  Choe,et al.  Sulfasalazine prevents T‐helper 1 immune response by suppressing interleukin‐12 production in macrophages , 1999, Immunology.

[28]  L. Cosmi,et al.  Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes , 2002, The Journal of experimental medicine.

[29]  U. Wagner,et al.  The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. , 1998, Journal of immunology.

[30]  R. Winchester The molecular basis of susceptibility to rheumatoid arthritis. , 1994, Advances in immunology.

[31]  M. Lebwohl,et al.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. , 1999, The Journal of clinical investigation.

[32]  J. Saurat,et al.  A common precursor for CD4+ T cells producing IL-2 or IL-4. , 1992, Journal of immunology.

[33]  H. Weiner Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. , 2001, Microbes and infection.

[34]  P. Ferrara,et al.  Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13 , 1996, European journal of immunology.

[35]  C. Thompson,et al.  Regulation of surface and intracellular expression of CTLA4 on mouse T cells. , 1996, Journal of immunology.

[36]  M. Dougados,et al.  Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. , 2003, The New England journal of medicine.

[37]  P. Lipsky,et al.  Anti-CD4 monoclonal antibody therapy in human autoimmune diseases. , 2000, Current directions in autoimmunity.

[38]  C. June,et al.  Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.

[39]  H. Schumacher,et al.  Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. , 1998, The Journal of rheumatology.

[40]  J. Bijlsma,et al.  Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance , 1998, Annals of the rheumatic diseases.

[41]  M. Salmon,et al.  Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis‐prone population , 2001, European journal of immunology.

[42]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[43]  Abo,et al.  Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti‐inflammatory role , 1998, Clinical and experimental immunology.

[44]  A. McMichael,et al.  Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. , 2001, Arthritis and rheumatism.

[45]  M. Rieder,et al.  An alternate mechanism of glucocorticoid anti‐proliferative effect: promotion of a Th2 cytokine‐secreting profile , 1999, Clinical transplantation.

[46]  M. Mack,et al.  Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease , 2003, Nature Medicine.

[47]  Ethan M. Shevach,et al.  Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease , 2002, The Journal of Immunology.

[48]  S. Sriram,et al.  Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 , 1985, The Journal of experimental medicine.

[49]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[50]  F. Breedveld,et al.  T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset , 1992, Scandinavian Journal of Immunology.

[51]  R. Williamson,et al.  Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. , 1998, The Biochemical journal.

[52]  M. Harigai,et al.  IL‐4 down‐regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM‐rheumatoid factor production in patients with rheumatoid arthritis , 1992, Clinical and experimental immunology.

[53]  R. Holmdahl,et al.  Influence of CD4 or CD8 deficiency on collagen‐induced arthritis , 2001, Immunology.

[54]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[55]  G. Krueger,et al.  Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. , 2001, The New England journal of medicine.

[56]  D. Mason,et al.  Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro , 2001, European journal of immunology.

[57]  P. Krammer,et al.  Involvement of Jun and Rel Proteins in Up-regulation of Interleukin-4 Gene Activity by the T Cell Accessory Molecule CD28* , 1998, The Journal of Biological Chemistry.

[58]  D. Isenberg,et al.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.

[59]  P. Miossec,et al.  Rheumatoid Inflammatory T‐Cell Clones express mostly Th1 but also Th2 and Mixed (Th0‐Like) Cytokine Patterns , 1993, Scandinavian journal of immunology.

[60]  G. Müller,et al.  Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. , 2000, The Journal of rheumatology.

[61]  K. De Groot,et al.  Wegener's granulomatosis: disease course, assessment of activity and extent and treatment , 1998, Lupus.

[62]  A. Calin,et al.  Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial , 1985 .

[63]  H. Paulus,et al.  Lymphocyte Involvement in Rheumatoid Arthritis , 1977 .

[64]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[65]  R. V. van Lier,et al.  Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. , 1999, Rheumatology.

[66]  A. Poole,et al.  The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. , 1992, Cellular immunology.

[67]  J. Banchereau,et al.  Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. , 1992, Arthritis and rheumatism.

[68]  F. Birg,et al.  Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. , 1992, Journal of immunology.

[69]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[70]  T. Spector,et al.  The role of pregnancy in the course and aetiology of rheumatoid arthritis , 1992, Clinical Rheumatology.

[71]  S. Hori,et al.  Control of autoimmunity by naturally arising regulatory CD4+ T cells. , 2003, Advances in immunology.

[72]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[73]  L. Zhang,et al.  Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. , 1999, Journal of immunology.

[74]  E. Shevach,et al.  Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. , 2004, Seminars in immunology.

[75]  D. Yocum,et al.  T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. , 1999, Seminars in arthritis and rheumatism.

[76]  L. Davis,et al.  Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. , 1995, Journal of immunology.

[77]  R. Germain T-cell development and the CD4–CD8 lineage decision , 2002, Nature Reviews Immunology.

[78]  M. Roncarolo,et al.  Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.

[79]  P. Lehner,et al.  CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[80]  L. Joosten,et al.  Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis , 1999, Arthritis research.

[81]  L. Davis,et al.  Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. , 1998, The Journal of rheumatology.

[82]  M. Lebwohl,et al.  CTLA 4 Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris , 1999 .

[83]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[84]  E. Lightfoot,et al.  Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. , 1991, Journal of immunology.

[85]  C. Baecher-Allan,et al.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.

[86]  J. Bijlsma,et al.  CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. , 2004, Arthritis and rheumatism.

[87]  A. Weiss T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases , 1993, Cell.

[88]  Stanley B. Cohen,et al.  Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. , 2002, Arthritis and rheumatism.

[89]  A. Calin,et al.  Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. , 1989, Arthritis and rheumatism.

[90]  L. Klareskog,et al.  CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease , 2004, Arthritis research & therapy.

[91]  J. Banchereau,et al.  Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[92]  C W Turck,et al.  ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. , 1992, Cell.

[93]  L. Davis,et al.  Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. , 1994, Arthritis and rheumatism.

[94]  Hergen Spits,et al.  Development of alphabeta T cells in the human thymus. , 2002, Nature reviews. Immunology.

[95]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[96]  S. Serjeantson,et al.  Evidence for oligoclonality of T cell receptor δ chain transcripts expressed in rheumatoid arthritis patients , 1992, European journal of immunology.

[97]  B. Mazières,et al.  Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. , 1998, Arthritis and rheumatism.

[98]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[99]  S. Paget,et al.  Predominantly T-cell infiltrate in rheumatoid synovial membranes. , 1975, The New England journal of medicine.

[100]  K. Oizumi,et al.  Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. , 1998, The Journal of rheumatology.

[101]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[102]  W. Seaman,et al.  Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.

[103]  J. Bluestone,et al.  The B 7 and CD 28 receptor families , 2022 .